Mycenax Biotech Inc.

Mycenax Biotech Inc. is rated 3 out of 5 in the category biotechnology. Read and write reviews about Mycenax Biotech Inc.. Established in 2001, Mycenax Biotech Inc. (MBI) has served our clients from Asia Pacific, Europe and North America for over 15 years to satisfy their business needs from cell line development to GMP manufacture with a data driven, science based and result oriented approach. Equipped with CMC based platform, disposable technology and PIC/S GMP manufacturing system, we dedicate to deliver satisfactory results by providing a high quality, cost-competitive and full line solution to develop and manufacture biological products. Today, MBI’s maximum scale of production for cell culture and microbial fermentation are, respectively, 2,000 L process and 50 L one. We have proven our capacity for planning and executing process development in a GMP-complaint, cost-effective, and time-efficient fashion, by passing IND and supplying clinical drug. In the near future, we will focus biobetters or bionovels as the target of development or co-development. Our target is to specialize in protein drugs, including new biological entities and biosimilars. Our mission is to be the best trustworthy partner in Asia Pacific to accelerate clients’ biopharmaceutical developments. Our vision is to launch value added and affordable products from bench to better human life.